MS Spasticity

Sativex® (nabiximols) has been developed as a treatment for the relief of symptoms in patients with moderate to severe spasticity due to multiple sclerosis (MS) that has not been adequately treated with currently used therapies.  Sativex® is not approved in all countries.  Please consult with your doctor if you would like more information.

There are a number of organizations which provide invaluable help, information and support to people experiencing health problems. They are also a useful source of information for those caring for others with long-term conditions or for friends and relatives. We list below links to the websites of some of the patient organizations you may find useful.

Multiple Sclerosis Links:

For more relevant information on the most common symptoms of Multiple Sclerosis (MS), as well as its causes, signs, incidence and available treatments, please visit the following website (hosted by Almirall)

Summary of Product Characteristics